Tiziana Life Sciences announces $4 million grant awarded by NIH to study anti-CD3 in Alzheimer’s disease: New York Saturday, September 21, 2024, 14:00 Hrs [IST] Tiziana Life Sci ...

Rice University and Baylor College of Medicine  have received $2.8 million in funding from the National Heart, Lung, and Blood Institute (NHLBI), a division of the National ...

Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, ...

Rice University and Baylor College of Medicine have received $2.8 million in funding from the National Heart, Lung, and Blood ...

Analyst Cory Jubinville, PhD of LifeSci Capital maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report), retaining the ...

The worldwide incidence of food allergies continues to increase especially in children therefore, prevention remain a public ...

Initiated by the Global Sepsis Alliance in 2012, World Sepsis Day falls on Sept 13 each year. Sepsis remains a global health-care problem that affects all age groups. The extrapolated annual incidence ...

The EU’s revised MDR 2017/745 was introduced in 2017 and became fully applicable to all medical devices on 27 May 2024.

Mallinckrodt plc, a global specialty pharmaceutical company, announced that the THERAKOS™ CELLEX™ Photopheresis System has ...

The Cambridge company was founded as an RNA-focused spinout of Beam Therapeutics. The startup is initially focused on the ...

By combining engineering strategies for enhanced mucosal delivery with a better understanding of immune mechanisms in the NALT and BALT, we hope to illustrate the potential of these mucosal sites as ...